Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: E who wrote (2814)	7/23/1999 3:09:00 PM
From: Jacques Chitte	Respond to of 4140

marketwatch.newsalert.com The story I hear (and I cannot confirm or deny) is that they presented 18-month data and the Board wanted 24 month data. Let's pretend this is fact. It opens a few cans of worms. 1) Was the requirement for 24 month data a complete surprise? An FDA application is not "closed book". There is a continual dialog between company and reviewers. So SNRS staff must have had some sort of reassurance that the FDA considered SNRS data to be complete and satisfactory. And then we have the PMA ambush. 1a) Is this a fair interpretation? 1b) Who knew about this ahead of time? There was some foreknowledge, cuz the shorts closed in on this in the last month. Shorts might be a lot of things, but dumb isn't one. 2) Was somebody at the company simply Not Listening? The nicest thing I can say about corporate leadership is that they are proven politically naive. This is bad imo - it ruins our previous conception of them as Stright Shooters. The stock price well below $4 now seems to corroborate this. 3) The company needs to present a clear, credible plan for its next 12 months of operations. How dilutive will the next round of financing be? Could it be that SNRS will die a Floorless Death? 4) Is there a White Knight? If SNRS technology is good after all, we may be watching a ploy to snap the co uo cheap. Unless SNRS can convince the once-bitten investor that they have a Plan, one that will pass Real World 101 this time - they should undo their poison pill and let themselves be bought. I, Investor, call on SNRS management to speak on these issues. Your survival hinges on it.